Target intelligence / Profile preview

Cellular hypoxia

Molecular classification
Other (not a receptor, enzyme, transporter, transcription factor, or single molecule)
01

Overview

Cellular hypoxia is a physiological state in which cells experience insufficient oxygen supply to maintain normal function, causing a broad spectrum of adaptive metabolic, transcriptional, and signaling responses[1][7][9]. These include stabilizing hypoxia-inducible factors (HIFs), shifting metabolism from oxidative phosphorylation to glycolysis, modulating cell proliferation, survival, and inducing angiogenesis, as well as promoting pathophysiological states such as cancer, ischemic injury, and inflammation[8][4][1]. Cellular hypoxia is not a druggable molecule itself but rather a context or condition; therapeutic interest focuses on targeting the hypoxia signaling pathways, especially HIFs and oxygen-sensing enzymes[10][8][1].\n\nKey point: Cellular hypoxia is not a canonical molecular target such as a receptor or enzyme for direct drug action, but refers to a state of oxygen deprivation that triggers specific molecular responses, which can serve as therapeutic targets.

Other names
Hypoxic statetissue hypoxiacellular oxygen deprivationintracellular hypoxiahypoxic microenvironment
02

Biological functions

Metabolic adaptation and shift to glycolysisRegulation of cell survival and deathModulation of cell proliferationInduction of angiogenesisCellular stress responseImmune modulation
03

Disease associations

CancerCardiovascular disease (e.g., myocardial infarction, stroke)Chronic and acute ischemic diseasesInflammatory/immune diseaseTumorigenesisWound healing impairmentInfectionOther diseases where oxygen limitation is pathogenic
04

Safety considerations

therapeutic targeting of hypoxia signaling risks disrupting oxygen homeostasis, leading to anemia, impaired wound healing, or off-target modulation of tumor growth or immune response
05

Biomarkers

HIF-1αHIF-2αdownstream hypoxia-responsive gene products (e.g., VEGF, GLUT1)

Beyond the preview

Go deeper on Cellular hypoxia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular hypoxia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call